Literature DB >> 2280147

Inner ear cholesteatoma and the preservation of cochlear function.

R Gamoletti, M Sanna, C Zini, A K Taibah, E Pasanisi, L Vassalli.   

Abstract

Labyrinthine destruction by direct cholesteatoma invasion has always been considered a serious threat to the inner ear function. A number of reports in the literature have cited both patients who had preservation of hearing despite widespread erosion of the labyrinth by cholesteatoma and patients who had retained auditory function despite surgical removal of the matrix from the labyrinth. In most cases the vestibular portion of the inner ear was invaded but cases of cochlear involvement have been described as well. Twelve cases with pre-operative auditory function preservation despite extensive labyrinthine destruction treated at our Institution are reported. Seven cases retained cochlear function post-operatively. Possible explanations of this occurrence and implications of related with hearing preservation in the presence of widespread inner ear destruction by chronic inflammatory disease are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2280147     DOI: 10.1017/s0022215100114446

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Cholesteatoma Induced Labyrinthine Fistula: Is Aggressiveness in Removing Disease Justified?

Authors:  Prem Sagar; K Devaraja; Rajeev Kumar; Sumanth Bolu; Suresh C Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-19

2.  Can cochlear function be preserved after a modified translabyrinthine approach to eradicate a huge cholesteatoma extending to the petrous apex?

Authors:  Sung Ju Hong; Jun Ho Lee; Sang Ho Jung; Chan Hum Park; Seok Min Hong
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-26       Impact factor: 2.503

3.  Management of cochlear fistula and the role of hearing: a five-case report.

Authors:  Maurizio Falcioni; Marco Govoni; Enrico Pasanisi; Filippo Di Lella
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-12       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.